Published: 13 February 2017
Author(s): Luis Castilla-Guerra, María del Carmen Fernandez-Moreno, Miguel Angel Colmero-Camacho
Section: Letter to the Editor

Disorders of glucose metabolism are highly prevalent among patients with established cerebrovascular disease. Up to 60% to 70% of patients may have dysglycemic state [1]. However, to date, insufficient evidence is available to show that stroke recurrence prevention will be improved by intensive glucose-lowering treatment in people with diabetes or related disorders. Moreover, no hypoglycemic drug has been proven to reduce subsequent strokes [1].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.